health
User access denied after restriction
A new COVID-19 antibody treatment, VYD2311, enters phase 3 trials to evaluate safety and efficacy against mRNA vaccines.
User access denied after policy breach
Dermatologists propose ending routine blood tests for isotretinoin patients without risk factors to streamline acne treatment.
User Blocked by Service
New PBM regulations in 2026 enhance transparency. Learn how industry changes impact healthcare practices.
User Blocked by Online Service
Employers encourage weight loss medications like GLP-1 receptor agonists through direct-to-consumer platforms and health savings accounts for employees.
User Blocked by Social Media Platform
Managing chronic conditions can be overwhelming, chronic care management is key to connected care experience for millions of Americans living with chronic…
Users blocked from accessing content online
Discover how Neffy generated $72.2 million in sales within its first year, securing insurance coverage from major providers like United Healthcare.
Service Apologizes for Blocking Users
Updated trial data shows the ALK inhibitor lorlatinib achieves record progression-free survival for lung cancer, potentially changing treatment guidelines.
User Accounts Blocked After Policy Violations
Physical inactivity is identified as the leading predictor of diabetes across U.S. counties, highlighting the urgent need for active lifestyles today.